HT-2157
- Generic Name
- HT-2157
Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder
Phase 1
Completed
- Conditions
- Healthy Volunteers (Part 1)Major Depressive Disorder (Part 2)
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-08-10
- Last Posted Date
- 2015-12-16
- Lead Sponsor
- Dart NeuroScience, LLC
- Target Recruit Count
- 26
- Registration Number
- NCT01413932
- Locations
- 🇺🇸
Clinical Site, Glendale, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath